PRESS RELEASES More events are coming soon. Keyword Search Year: 2022202120202019201820172016201520142013 08/08/22 Summary Toggle TRACON Pharmaceuticals Announces Submission of IND Application for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab Printer Friendly PDF Version 07/27/22 Summary Toggle TRACON to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 10, 2022 Printer Friendly PDF Version 07/26/22 Summary Toggle TRACON Pharmaceuticals Announces Dosing of 36th Patient in ENVASARC Pivotal Trial Triggering Initial IDMC Efficacy Review Expected in the Fourth Quarter Printer Friendly PDF Version 06/02/22 Summary Toggle TRACON Pharmaceuticals to Present at the Jefferies Healthcare Conference Printer Friendly PDF Version 05/16/22 Summary Toggle TRACON Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference Printer Friendly PDF Version 05/11/22 Summary Toggle TRACON Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update Printer Friendly PDF Version 05/04/22 Summary Toggle TRACON to Report First Quarter 2022 Financial Results and Corporate Update on May 11, 2022 Printer Friendly PDF Version 04/19/22 Summary Toggle TRACON Pharmaceuticals Announces Amended ENVASARC Protocol Approved and Open at all 30 Clinical Sites in the U.S. and U.K. Printer Friendly PDF Version 03/23/22 Summary Toggle TRACON Pharmaceuticals to Present at the Maxim Group 2022 Virtual Growth Conference Printer Friendly PDF Version 03/15/22 Summary Toggle TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update Printer Friendly PDF Version Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Page 4 … Next page Next Last page Last
